Bioorganic & Medicinal Chemistry Letters 2012-09-01

Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway.

Ian Bruce, Mohammed Akhlaq, Graham C Bloomfield, Emma Budd, Brian Cox, Bernard Cuenoud, Peter Finan, Peter Gedeck, Julia Hatto, Judy F Hayler, Denise Head, Thomas Keller, Louise Kirman, Catherine Leblanc, Darren Le Grand, Clive McCarthy, Desmond O'Connor, Charles Owen, Mrinalini S Oza, Gaynor Pilgrim, Nicola E Press, Lilya Sviridenko, Lewis Whitehead

Index: Bioorg. Med. Chem. Lett. 22(17) , 5445-50, (2012)

Full Text: HTML

Abstract

Using a parallel synthesis approach to target a non-conserved region of the PI3K catalytic domain a pan-PI3K inhibitor 1 was elaborated to provide alpha, delta and gamma isoform selective Class I PI3K inhibitors 21, 24, 26 and 27. The compounds had good cellular activity and were selective against protein kinases and other members of the PI3K superfamily including mTOR and DNA-PK.Copyright © 2012 Elsevier Ltd. All rights reserved.

Related Compounds

  • 2-Aminothiazole

Related Articles:

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

2008-11-13

[J. Med. Chem. 51 , 6740-51, (2008)]

Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase.

2008-06-01

[Bioorg. Med. Chem. 16 , 6193-206, (2008)]

Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.

2015-04-01

[Neurourol. Urodyn. 34(4) , 368-74, (2015)]

Multicomponent assembly of proposed DNA precursors in water.

2012-08-22

[J. Am. Chem. Soc. 134(33) , 13889-95, (2012)]

A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors.

2013-03-01

[ChemMedChem 8(3) , 484-96, (2013)]

More Articles...